When
February 8, 2024
9:30 am - 1:30 pm ET
Where
Organizer
Presentations
“Advances in Early Detection of Psychosis using Brain Imaging” Daphne Holt, MD, PhD
“Digital Innovations in Youth Suicide Prediction and Prevention” Taylor Burke, PhD
“Novel Treatments for Depression” Maurizio Fava, MD
Featured Speakers
Maurizio Fava, MD
Psychiatrist-In-Chief, Department of Psychiatry
Director, Division of Clinical Research, Mass General Research Institute
Executive Director, Clinical Trials Network & Institute
Associate Dean for Clinical & Translational Research, Slater Family Professor of Psychiatry, Harvard Medical School
Dr. Maurizio Fava is Psychiatrist-in-Chief of the Massachusetts General Hospital (MGH); Vice Chair, the MGH Executive Committee on Research; and executive director of the Clinical Trials Network and Institute, (MGH). He holds the Slater Family Professorship in Psychiatry and is Associate Dean for Clinical and Translational Research at Harvard Medical School.
Dr. Fava received his medical degree from the University of Padova School of Medicine in Italy, and completed his residency in Psychiatry at Mass General.
Dr. Fava is a world leader in the field of depression. He has obtained research funding for over $150 million and has authored or co-authored more than 900 original articles published in medical journals with international circulation, editing eight books and publishing more than 50 chapters and 500 abstracts. He founded and directed MGH’s Depression Clinical and Research Program from 1990 until 2014. The program is one of the most highly regarded depression programs in the country, and a model for academic programs that connect, in a bi-directional fashion, clinical care and research.
Taylor Burke, PhD
Director, Pediatric Computational Health, Center for Precision Psychiatry
Associate Director, Suicide Research in the Division of Child and Adolescent Psychiatry
Assistant Professor of Psychology, Harvard Medical School
Taylor A. Burke is an Assistant Professor of Psychology in the Department of Psychiatry at Harvard Medical School and a licensed clinical psychologist. She is the Director of Pediatric Computational Health in the Center for Precision Psychiatry and Associate Director of Suicide Research in the Division of Child and Adolescent Psychiatry at Massachusetts General Hospital. The primary aim of Dr. Burke’s research is to advance the prediction and prevention of self-injurious thoughts and behaviors (SITBs) among youth and young adults. Dr. Burke uses novel methodologies and computational approaches to improve the identification of individuals at risk to better intervene and prevent SITBs. She has published over 70 peer-reviewed articles and book chapters on the etiology of SITBs and related psychopathology, and has obtained grant funding in this area totaling approximately $2 M. Dr. Burke holds a five-year NIMH career development award that focuses on using passive mobile sensing, adolescent sleep, and physical activity assessment, and advanced computational approaches to idiographic modeling to develop proximal risk models for increases in suicidal ideation. She also has other ongoing research supported by the American Foundation for Suicide Prevention and the NIMH focused on leveraging computer vision to enhance suicide risk screening in a range of settings. Her program of research has been nationally recognized for its contribution to child and adolescent psychological science by her receipt of the Future Directions Launch Award from the Journal of Clinical Child and Adolescent Psychology.
Daphne Holt, MD, PhD
Co-Director, Psychosis Clinical and Research Program, Massachusetts General Hospital
Director of the Resilience and Prevention Program and the Emotion and Social Neuroscience Laboratory, Massachusetts General Hospital
Associate Professor of Psychiatry, Harvard Medical School
Dr. Daphne J. Holt is an Associate Professor of Psychiatry at Harvard Medical School, Co-Director of the Psychosis Clinical and Research Program, and Director of the Resilience and Prevention (RAP) Program and the Emotion and Social Neuroscience Laboratory, at MGH.
Dr. Holt attended medical school at the University of Chicago Pritzker School of Medicine, where she also received a PhD in neurobiology. She received her training in adult psychiatry in the Massachusetts General/McLean Hospital Adult Psychiatry Residency Program, becoming a faculty member of the Massachusetts General Hospital Psychiatry Department in 2004.
Dr. Holt’s research focuses on understanding the neural basis of emotional function and social behavior, and changes in these domains, in people who are affected by, or at risk for, serious mental illnesses. In addition, the RAP program she oversees is developing and testing interventions that may reduce risk for neuropsychiatric illness.
She has published peer-reviewed articles in journals such as JAMA Psychiatry, Molecular Psychiatry, Biological Psychiatry, Schizophrenia Bulletin, the Journal of Neuroscience, and NeuroImage, among others. Her research has been supported by grants from the National Institute of Mental Health, the Sidney R. Baer, Jr. Foundation, the Brain & Behavior Research Foundation, the MGH Executive Committee on Research (as a recipient of the Claflin Award and the MGH Research Scholar Award), the McCance Center for Brain Health and Mass General Neuroscience.
Gagan Joshi, MD
Director, Alan and Lorraine Bressler Clinical and Research Program for Autism Spectrum Disorder
Associate Professor of Psychiatry, Harvard Medical School
Dr. Gagan Joshi is the Director of the Alan and Lorraine Bressler Clinical and Research Program for Autism Spectrum Disorder. He is also Associate Professor of Psychiatry at the Harvard Medical School.
Dr. Joshi trained in General Psychiatry at the Hospital of the University of Pennsylvania and subsequently completed his Fellowship training in Child and Adolescent Psychiatry at the combined program of the Massachusetts General Hospital and McLean Hospital, Harvard Medical School. He received training in cognitive-behavioral therapy at the Beck Institute for Cognitive Therapy and trained in psychodynamic psychotherapy at the Philadelphia Psychoanalytic Institute & Society.
Dr. Joshi has been the recipient of the prestigious Ethel Dupont Warren Fellowship Award through the Department of Psychiatry at Harvard Medical School, the XXVth Collegium Internationale Neuro-Psychopharmalogicum Congress Young Investigators Award, the American Academy of Child & Adolescent Psychiatry Pilot Research Award, and the Norma Fine Fellowship.
Dr. Joshi’s clinical and research interest is in Autism Spectrum Disorder (ASD) with particular focus on the frequently associated psychopathologies. Besides coordinating Bressler clinic and providing clinical care to psychiatrically referred populations of all ages with ASD, Dr. Joshi is facilitating translational clinical research in intellectually capable ASD populations with psychopathology. At the Bressler Program, in collaboration with the McLean Hospital and the Massachusetts Institute of Technology, Dr. Joshi is conducting research focused on the clinical and neural characterization and psychopharmacotheraputics of ASD and related psychopathology with a particular emphasis on designing neuro-imaging informed pharmacotherapy trials by leveraging state of the art pharmaco-imaging techniques to help identify biomarkers of disease and treatment response.